These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16181464)

  • 1. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study.
    Kreuter A; Knierim C; Stücker M; Pawlak F; Rotterdam S; Altmeyer P; Gambichler T
    Br J Dermatol; 2005 Oct; 153(4):802-7. PubMed ID: 16181464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A.
    De Rie MA; Sommer A; Hoekzema R; Neumann HA
    Br J Dermatol; 2002 Oct; 147(4):743-7. PubMed ID: 12366422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of noninfectious granulomatous skin diseases with fumaric acid esters.
    Breuer K; Gutzmer R; Völker B; Kapp A; Werfel T
    Br J Dermatol; 2005 Jun; 152(6):1290-5. PubMed ID: 15948995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated granuloma annulare--treatment with fumaric acid esters.
    Eberlein-König B; Mempel M; Stahlecker J; Forer I; Ring J; Abeck D
    Dermatology; 2005; 210(3):223-6. PubMed ID: 15785051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumaric acid esters in severe ulcerative necrobiosis lipoidica: a case report and evaluation of current therapies.
    Eberle FC; Ghoreschi K; Hertl M
    Acta Derm Venereol; 2010; 90(1):104-6. PubMed ID: 20107745
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
    Mrowietz U; Christophers E; Altmeyer P
    Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of necrobiosis lipoidica with fumaric acid esters.
    Gambichler T; Kreuter A; Freitag M; Pawlak FM; Brockmeyer NH; Altmeyer P
    Dermatology; 2003; 207(4):422-4. PubMed ID: 14657645
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
    Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
    Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
    Balasubramaniam P; Stevenson O; Berth-Jones J
    Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study.
    Tzaneva S; Geroldinger A; Trattner H; Tanew A
    Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate - only an anti-psoriatic medication?
    Meissner M; Valesky EM; Kippenberger S; Kaufmann R
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):793-801. PubMed ID: 22897153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.
    Harries MJ; Chalmers RJ; Griffiths CE
    Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria with fumaric acid ester treatment for psoriasis.
    Ogilvie S; Lewis Jones S; Dawe R; Foerster J
    Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant granuloma annulare and necrobiosis lipoidica. Report of a case and review of the literature.
    Crosby DL; Woodley DT; Leonard DD
    Dermatologica; 1991; 183(3):225-9. PubMed ID: 1743389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity and Therapeutic Approaches in Patients with Necrobiosis Lipoidica.
    Erfurt-Berge C; Heusinger V; Reinboldt-Jockenhöfer F; Dissemond J; Renner R
    Dermatology; 2022; 238(1):148-155. PubMed ID: 33827092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study.
    Dickel H; Bruckner T; Altmeyer P
    J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1710-1727. PubMed ID: 29705996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST).
    Weisenseel P; Reich K; Griemberg W; Merten K; Gröschel C; Gomez NN; Taipale K; Bräu B; Zschocke I
    J Dtsch Dermatol Ges; 2017 Feb; 15(2):180-186. PubMed ID: 28214304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.
    Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN
    Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature.
    Suárez-Amor O; Pérez-Bustillo A; Ruiz-González I; Rodríguez-Prieto MA
    Dermatology; 2010; 221(2):117-21. PubMed ID: 20805688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients.
    Erfurt-Berge C; Seitz AT; Rehse C; Wollina U; Schwede K; Renner R
    Eur J Dermatol; 2012; 22(6):770-5. PubMed ID: 23114030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.